In contrast to the classic portable blood glucose meter, which requires each "finger-tapping" measurement, continuous blood sugar monitoring (CGM) technology can continuously detect and track blood sugar through a microsensor implanted with subsultural fibers, and prompt the measurement results via electronic devices to alert you when blood sugar is too low or too high.
for patients who need insulin-enhanced treatment, especially those with type 1 diabetes, the guidelines recommend continuous blood glucose monitoring to better stabilize blood sugar control and reduce the risk of hypoglycemia.
benefits of continuous blood glucose monitoring? A recent study published in the Journal of the American Diabetes Association (ADA), Diabetes Care, provides new answers that demonstrate the long-term and multi-faceted positive effects of continuous blood glucose monitoring.
follow-up time was about six and a half years compared to the previous clinical trial' assessment of the effectiveness of continuous blood glucose monitoring.
: The Diabetes Care study, conducted by a team from the University of Gothenburg, included 108 adults with type 1 diabetes who needed multiple daily insulin injections at 13 hospitals in Sweden.
with regular (every 3 months) support from diabetes nurses, 107 of them were continuously monitored for blood sugar for more than a year.
the average glycation hemoglobin (HbA1c) levels in patients decreased by 0.35 percent over a 1-1.5-year period of continuous blood sugar monitoring compared to previous self-glucose monitoring using conventional techniques.
after 2.3 and 2.5 years, HbA1c decreased by an average of 0.45 per cent and 0.68 per cent, respectively.
also reduced the onset of hypoglycemia by about 70 percent in patients with the disease.
the time ratio of blood sugar to 3.0 mmol/L decreased from 2.1% to 0.6%, and the time ratio of blood sugar to 4.0 mmol/L decreased from 5.4% to 2.9%.
blood sugar fluctuates less, which also results in a significant increase in overall well-being, treatment satisfaction, anxiety about hypoglycemia, and reduced diabetes management problems.
this trial analysis supports the long-term medical and mental health effects of continuous blood glucose monitoring on patients.
, a professor of diabetes at the University of Gothenburg and the head of the trial, said, "It's important for treatment policy makers to make judgments based on long-term data evidence."
addition, there are many people with type 1 diabetes who do not use CCM technology, and these long-term benefit data are important for people with type 1 diabetes worldwide.
" References, Marcus Lind, et al., (2020). Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI. Diabetes Care, DOI: Good long-term effects of continuous glucose monitoring. Retrieved November 23, 2020, from